Physician profile
Tamara A Mason
NPI 1821067067
$1,622.03
in general payments reported to CMS, 2019-2025
16 companies · $441 in 2025
The $441 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.03 · 2020: $46.56 · 2021: $64.27 · 2022: $126 · 2023: $235 · 2024: $654 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $343.06 | 2023-2024 | Jornay Pm |
| Corium, LLC | $332.28 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $285.16 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $150.93 | 2022-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $93.88 | 2022-2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $87.22 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $65.28 | 2024-2025 | Relexxii |
| Noven Therapeutics, LLC | $57.60 | 2024 | Xelstrym |
| Neos Therapeutics, Lp | $57.47 | 2023-2024 | Adzenys Xr-Odt |
| Merck Sharp & Dohme LLC | $54.45 | 2019-2021 | |
| Sanofi Pasteur INC. | $19.42 | 2022 | |
| Noven Pharmaceuticals, INC. | $18.16 | 2024 | Xelstrym |
| Pfizer INC. | $17.69 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $15.24 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.89 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $11.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.